Cataract Clinical Trial
— MICSOfficial title:
Comparison of Surgically Induced Astigmatism After Microincision Cataract Surgery (B-MICS 1.4 mm and C-MICS 1.8 mm) and C- SICS 2.4 mm
Verified date | August 2022 |
Source | Medical University of Lodz |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to compare functional results and complications of 3 methods of cataract phacoemulsification: bimanual 1.4 mm cataract surgery (B-MICS), coaxial 1.8 mm cataract surgery (C-MICS) and coaxial 2.4 mm small incision cataract surgery.
Status | Completed |
Enrollment | 90 |
Est. completion date | May 1, 2019 |
Est. primary completion date | January 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years to 87 Years |
Eligibility | Inclusion Criteria: - lens opacities which were an indication for cataract surgery and absence of exclusion criteria, - cataract sclerosis grade from II to IV in Lens Opacities Classification System LOCS III scale (The Lens Opacities Classification System III). Exclusion Criteria: - history of ocular surgery, ocular trauma, - congenital ocular malformations, amblyopia, - corneal disorders (including corneal opacities and scars), - best corrected visual acuity (BCVA) = 0.9, - preoperative endothelial cell density <1500 cells/mm2, - history of uveitis, diabetic retinopathy, - retinal and macular disorders, - eventful phacoemulsification - presence of other diseases that could affect the postoperative visual outcomes. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Medical University of Lodz |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the best corrected visual acuity | examined with digital Snellen chart, measured in decimal scale | 36 months | |
Primary | the best uncorrected visual acuity | examined with digital Snellen chart, measured in decimal scale | 36 months | |
Primary | autorefractometry | measured in diopters (D) | 36 months | |
Primary | keratometry | measured in diopters (D) | 36 months | |
Primary | intraocular pressure (IOP) | measured in millimeters of mercury (mmHg) | 36 months | |
Primary | endothelial cell density (ECD) | measured in endothelial cells/mm2 | 36 months | |
Primary | central corneal thickness (CCT) | measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers). | 36 months | |
Primary | peripheral temporal corneal thickness | measured at the main incision site with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers) | 36 months | |
Primary | peripheral nasal corneal thickness | measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers) | 36 months | |
Primary | anterior chamber depth (ACD) | measured with Anterior Segment Optical Coherence Tomography (AS-OCT) in mm (milimeters). | 36 months | |
Primary | the white-to-white (WTW) distance - the horizontal corneal diameter | measured with Anterior Segment Optical Coherence Tomography (AS-OCT, unit of measure: mm (milimeters). | 36 months | |
Primary | length of the clear corneal incision | the chord length measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers) | 36 months | |
Primary | anterior chamber angle | measured with Anterior Segment Optical Coherence Tomography (AS-OCT) in horizontal scan, unit of measure: degrees | 36 months | |
Primary | central foveal thickness (CFT) | measured with Optical Coherence Tomography (OCT), unit of measure: µm (micrometers) | 36 months | |
Primary | parafoveal retinal thickness | measured with Optical Coherence Tomography (OCT), unit of measure: µm (micrometers) | 36 months | |
Secondary | surgically induced astigmatism SIA | measured in dioptres (D) - three different methods were used for calculation of surgically induced astigmatism (SIA): vector analysis method, vector decomposition method (C90), Naeser's polar values method (dKP-90) | 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |